Media & Entertainment » Movie, TV & Radio | American Cryostem Corp.

American Cryostem Corp. | Balance Sheet

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
115.90
21.50
9.10
37.30
410.30
68.30
Total Accounts Receivable
2.00
6.10
56.50
65.30
171.90
218.10
Inventories
-
-
7.80
24.70
27.70
33.70
Other Current Assets
-
-
-
-
33.30
48.90
Total Current Assets
117.90
27.50
73.30
127.30
643.20
369.10
Net Property, Plant & Equipment
281.40
250.20
211.30
182.70
52.40
244.70
Total Investments and Advances
5.80
6.80
1.00
1.00
1.00
301
Long-Term Note Receivable
-
-
2.30
10.90
-
0.20
Intangible Assets
163.90
200.80
239.80
256.50
299.10
338
Other Assets
-
54.80
6.00
13.50
13.50
13.50
Total Assets
569.00
540.10
533.60
591.90
1,009.20
1,266.40
ST Debt & Current Portion LT Debt
20.20
779.90
1,133.00
412.90
1,090.50
Accounts Payable
260.10
698.10
807.20
831.60
805.90
Other Current Liabilities
0.00
17.80
56.40
28.50
25.70
Total Current Liabilities
280.40
1,495.80
1,996.60
1,273.00
1,922.10
Long-Term Debt
201.70
164.90
50.00
1,148.50
-
Other Liabilities
139.50
-
118.40
117.20
108.70
Total Liabilities
621.50
1,660.70
2,165.00
2,538.70
2,030.80
Common Equity (Total)
52.50
1,120.60
1,631.30
1,946.80
1,021.60
Total Shareholders' Equity
52.50
1,120.60
1,631.30
1,946.80
1,021.60
Total Equity
52.50
1,120.60
1,631.30
1,946.80
1,021.60
Liabilities & Shareholders' Equity
569.00
540.10
533.60
591.90
1,009.20

About American Cryostem

View Profile
Address
1 Meridian Road
Eatontown New Jersey 07724
United States
Employees -
Website http://www.americancryostem.com
Updated 07/08/2019
American CryoStem Corp. engages in the development, market, and licenses patented adipose tissue-based cellular technologies, bio-materials, and related proprietary services. It focuses on clinical processing, commercial bio-banking, and application development for adipose tissue and adipose-derived stem cells; and also provides contract manufacturing services to physicians and other medical professionals that perform tissue transfer and other cellular therapy services, as well as offers professional services, including sterility, viability, cellular density, and growth assay analysis. The company was founded by Anthony Francis Dudzinski on November 18, 2008 and is headquartered in Eatontown, NJ.